European Archives - Page 911 of 1259 - European Medical Journal

This site is intended for healthcare professionals

Continue
2 Mins
11 Oct 2018

The Effect of Renin-Angiotensin System Blockade on Long-Term Outcomes Following Transcatheter Aortic Valve Implantation

Several studies have demonstrated the benefits of transcatheter aortic valve implantation (TAVI) in high and intermediate-risk patients, but there is…
8 Mins
11 Oct 2018

A Comparison of Different Doses of Dexmedetomidine for Myocardial Protection in Percutaneous Coronary Interventional Patients

Acute myocardial infarction (MI) is a major cause of death and disability worldwide. Myocardial injury in acute MI is due to both ischaemic as well…
1 Mins
11 Oct 2018

Effect of Renin-Angiotensin System Blockade in the Prevention of Thoracic Aortic Aneurysm Progression

Data are limited on the efficacy of medical therapies for non-syndromic thoracic aortic aneurysms (TAA), with expression of disease-causing genes…
10 Mins
11 Oct 2018

Cardioprotective Approaches to the Management of Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Do We Need Increased Surveillance in Elderly Women on Trastuzumab?

Due to recent advances in antineoplastic treatment for breast cancer, cancer-related mortality has substantially decreased. However, several systemic…
1 Mins
11 Oct 2018

High Cardiovascular Risk is Associated with the Degree of Fibrosis in Nonalcoholic Liver Disease

Cardiovascular diseases remain the leading cause of death worldwide. Nonalcoholic fatty liver disease (NAFLD), encompassing steatosis, nonalcoholic…
7 Mins
11 Oct 2018

The Cardiomyopathy of Iron Deficiency Anaemia

Anaemia is a significant challenge in global health; it is characterised by lower than normal levels of red blood cells and haemoglobin per unit volume…
1 Mins
11 Oct 2018

Prognostic Role of Cardiac Power Index in Patients with Biopsy-Proven Inflammatory Cardiomyopathy

Most patients with acute myocarditis and mild cardiac involvement recover without long-term sequelae. However, those patients with advanced cardiac…
13 Mins
11 Oct 2018

Treatment of Chronic Chagasic Patients: Is Killing the Parasite the Only Option?

Chronic Chagasic cardiomyopathy (CCC) is one of the principal challenges for clinicians treating asymptomatic Chagasic patients. Only benznidazole (BZ)…
2 Mins
11 Oct 2018

Risk Stratification and Age-Adjusted D-Dimer Test: Are They Satisfactory in Acute Pulmonary Embolism?

Pulmonary embolism (PE) is associated with high morbidity and mortality and often has a nonspecific clinical presentation; thus, prognostic assessment…
10 Oct 2018

An interview with Giles Platford from Takeda

An interview with Giles Platford, President Europe & Canada, Takeda Pharmaceutical Company Limited at the eyeforpharma conference, Barcelona, 2018. Mr Platford discusses Takeda’s Patient-Trust-Reputation-Business decision-making model to ensure the patient is at the heart of everything and what it takes to successfully manage a team and inspire innovation, while striving for sustainable business growth.
We’ve noticed you’re accessing
from North/South America.